At 9 months (early AD), TgF344-AD rats show hippocampal accumulation of amyloid plaques and tau hyperphosphorylation 42,43, cerebrovascular dysfunction, and reduced hippocampal glucose uptake 44. The gene discussed is MAPT; the disease is Alzheimer disease.